Lowering a specific microRNA to help brain immune cells clear Alzheimer's proteins
Targeting specific MicroRNA to alleviate Alzheimer’s Disease pathobiology
A project to lower a specific microRNA to help brain immune cells remove amyloid in people with Alzheimer's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11298948 on NIH RePORTER |
What this research studies
If I or a loved one has Alzheimer's, this research focuses on a tiny genetic regulator called a microRNA that appears to block the brain's cleanup machinery in immune cells called microglia. The team found this microRNA is higher in brains from people with Alzheimer's and in mouse models, and they will study why its levels go up. They will reduce the microRNA in mice to see whether microglia clear amyloid-β better and whether cell-cleaning (autophagy) improves, while comparing results to human brain samples. The work combines experiments in mice with analysis of human tissue to explore whether targeting this microRNA could lead to new treatment ideas.
Who could benefit from this research
Good fit: Ideal candidates would be older adults with Alzheimer's disease or families willing to donate brain tissue or share clinical records for research.
Not a fit: People without Alzheimer's or whose dementia stems from non-amyloid causes are unlikely to receive direct benefit from this specific approach.
Why it matters
Potential benefit: If successful, targeting this microRNA could help brain immune cells clear amyloid and potentially slow Alzheimer's progression.
How similar studies have performed: Prior research has shown autophagy problems and some microRNA links in Alzheimer's, but targeting this specific microRNA in microglia is a relatively new, mostly preclinical approach with encouraging early data.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Amer, Amal O — Ohio State University
- Study coordinator: Amer, Amal O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.